Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D .
- Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D .
- as chief strategy officer of the organization, effective immediately.
- View the full release here: https://www.businesswire.com/news/home/20231120034416/en/
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer (Photo: Business Wire)
“The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team at Catalyst OrthoScience,” said Catalyst CEO and President Carl O’Connell . - Prior to Cutera and through the peak of the COVID-19 pandemic, Ables was the chief learning officer at Vyaire Medical, a global organization focused on respiratory care.